[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR100554549B1 - 9a-아잘리드류로부터 유래한 신규한 3,6-헤미케탈 - Google Patents

9a-아잘리드류로부터 유래한 신규한 3,6-헤미케탈 Download PDF

Info

Publication number
KR100554549B1
KR100554549B1 KR1020007004079A KR20007004079A KR100554549B1 KR 100554549 B1 KR100554549 B1 KR 100554549B1 KR 1020007004079 A KR1020007004079 A KR 1020007004079A KR 20007004079 A KR20007004079 A KR 20007004079A KR 100554549 B1 KR100554549 B1 KR 100554549B1
Authority
KR
South Korea
Prior art keywords
methyl
same
group
represent
compound
Prior art date
Application number
KR1020007004079A
Other languages
English (en)
Korean (ko)
Other versions
KR20010031160A (ko
Inventor
코브레헬가브리젤라
라자레브스키고르자나
빈코비크밀라덴
Original Assignee
플리바 파마세우츠카 인두스트리야, 디오닉코, 드러스트보
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HR970551A external-priority patent/HRP970551B1/xx
Priority claimed from HR980497A external-priority patent/HRP980497B1/xx
Application filed by 플리바 파마세우츠카 인두스트리야, 디오닉코, 드러스트보 filed Critical 플리바 파마세우츠카 인두스트리야, 디오닉코, 드러스트보
Publication of KR20010031160A publication Critical patent/KR20010031160A/ko
Application granted granted Critical
Publication of KR100554549B1 publication Critical patent/KR100554549B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
KR1020007004079A 1997-10-16 1998-10-13 9a-아잘리드류로부터 유래한 신규한 3,6-헤미케탈 KR100554549B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
HRP970551A 1997-10-16
HR970551A HRP970551B1 (en) 1997-10-16 1997-10-16 Novel o-methyl azythromycin derivatives
HRP980497A 1998-09-10
HR980497A HRP980497B1 (en) 1998-09-10 1998-09-10 NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES
PCT/HR1998/000005 WO1999020639A2 (en) 1997-10-16 1998-10-13 NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES

Publications (2)

Publication Number Publication Date
KR20010031160A KR20010031160A (ko) 2001-04-16
KR100554549B1 true KR100554549B1 (ko) 2006-03-03

Family

ID=26317108

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007004079A KR100554549B1 (ko) 1997-10-16 1998-10-13 9a-아잘리드류로부터 유래한 신규한 3,6-헤미케탈

Country Status (26)

Country Link
US (1) US6369035B1 (hu)
EP (2) EP1036083B9 (hu)
JP (1) JP2001520234A (hu)
KR (1) KR100554549B1 (hu)
CN (1) CN1281615C (hu)
AR (1) AR018014A1 (hu)
AT (2) ATE348836T1 (hu)
AU (1) AU755315B2 (hu)
BG (1) BG64650B1 (hu)
BR (1) BR9812808A (hu)
CA (1) CA2306963C (hu)
DE (2) DE69824201T2 (hu)
DK (2) DK1036083T5 (hu)
EE (1) EE04681B1 (hu)
ES (2) ES2222610T3 (hu)
HK (1) HK1032785A1 (hu)
HU (1) HUP0004085A3 (hu)
IL (2) IL135648A0 (hu)
NO (1) NO20001871L (hu)
NZ (1) NZ503897A (hu)
PL (1) PL191087B1 (hu)
PT (2) PT1437359E (hu)
RU (1) RU2220148C2 (hu)
SI (2) SI1036083T1 (hu)
SK (1) SK285914B6 (hu)
WO (1) WO1999020639A2 (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0104192A3 (en) * 1998-11-03 2003-12-29 Pfizer Prod Inc Novel macrolide antibiotics
KR100361397B1 (ko) * 2000-03-15 2002-11-23 한미약품공업 주식회사 에리스로마이신 에이 9-오-트로필옥심 유도체를 이용한클라리스로마이신의 제조방법
EP1482957A4 (en) 2002-02-15 2006-07-19 Merckle Gmbh ANTIBIOTIC CONJUGATES
EP1483277A4 (en) 2002-02-15 2007-10-03 Merckle Gmbh CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, METHODS OF PREPARATION AND USE, AND FORMULATION AND PHARMACEUTICAL APPLICATIONS
US20060099660A1 (en) 2002-02-15 2006-05-11 Synovo Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
HRP20020779A2 (en) 2002-09-27 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. NEW 3-DECLADINOSYL DERIVATIVES OF 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICIN A 9a, 11-CYCLIC CARBAMATES
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
US7435805B2 (en) 2003-05-30 2008-10-14 Glaxpsmithkline Istrazivacki O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
WO2004106353A1 (en) * 2003-05-30 2004-12-09 Pliva - Istrazivacki Institut D.O.O. Process for selective alkylation of macrolide and azalide derivatives
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7402568B2 (en) 2004-09-29 2008-07-22 Enanta Pharmaceuticals, Inc. Bicyclic 9a-azalide derivatives
US7271155B2 (en) 2005-01-07 2007-09-18 Enanta Pharmaceuticals, Inc. 9A, 11-2C-bicyclic 9a-azalide derivatives
WO2008106204A1 (en) * 2007-02-28 2008-09-04 Rib-X-Pharmaceuticals, Inc. Macrolide compounds and methods of making and using the same
US9145436B2 (en) 2010-10-10 2015-09-29 Michael W. Burnet Anti-inflammatory macrolides
CA2869461A1 (en) * 2012-03-27 2013-10-03 Michael W. BURNET Anti-inflammatory macrolides
JP7184520B2 (ja) * 2018-01-22 2022-12-06 旭化成株式会社 トランス型脂環式カーボネートの製造方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250518A (en) * 1990-07-18 1993-10-05 Pliva Farmaceutska, Kemijska, Prehrambena I Kozmeticka O-methyl derivatives of azithromycin A

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
RU2066324C1 (ru) * 1987-07-09 1996-09-10 Пфайзер Инк. Кристаллический дигидрат азитромицина и способ его получения
DE3860503D1 (de) * 1987-09-03 1990-10-04 Pliva Pharm & Chem Works 10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung.
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
FR2691464B1 (fr) * 1992-05-21 1995-06-02 Roussel Uclaf Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
WO1999000124A1 (en) * 1997-06-26 1999-01-07 Merck & Co., Inc. 9a-azalides, compositions containing such compounds and methods of treatment

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250518A (en) * 1990-07-18 1993-10-05 Pliva Farmaceutska, Kemijska, Prehrambena I Kozmeticka O-methyl derivatives of azithromycin A

Also Published As

Publication number Publication date
BG64650B1 (bg) 2005-10-31
BR9812808A (pt) 2005-04-12
EP1437359A2 (en) 2004-07-14
WO1999020639A2 (en) 1999-04-29
ES2279242T3 (es) 2007-08-16
PT1437359E (pt) 2007-04-30
DE69836697T2 (de) 2007-10-04
BG104445A (en) 2001-02-28
HK1032785A1 (en) 2001-08-03
SK285914B6 (sk) 2007-11-02
KR20010031160A (ko) 2001-04-16
EP1437359A3 (en) 2005-03-30
ATE267835T1 (de) 2004-06-15
NO20001871L (no) 2000-04-17
DK1036083T5 (da) 2005-04-04
IL135648A0 (en) 2001-05-20
CA2306963C (en) 2007-05-01
EP1437359B1 (en) 2006-12-20
DK1036083T3 (da) 2004-09-27
AU755315B2 (en) 2002-12-12
IL135648A (en) 2007-03-08
RU2220148C2 (ru) 2003-12-27
DE69824201D1 (de) 2004-07-01
CN1281615C (zh) 2006-10-25
DK1437359T3 (da) 2007-04-30
EP1036083B9 (en) 2005-01-12
EE200000226A (et) 2001-06-15
SI1437359T1 (sl) 2007-06-30
NZ503897A (en) 2002-10-25
HUP0004085A2 (hu) 2001-04-28
SK5522000A3 (en) 2000-11-07
US6369035B1 (en) 2002-04-09
SI1036083T1 (en) 2004-10-31
NO20001871D0 (no) 2000-04-11
PL340372A1 (en) 2001-01-29
PL191087B1 (pl) 2006-03-31
WO1999020639A3 (en) 1999-07-08
JP2001520234A (ja) 2001-10-30
DE69824201T2 (de) 2005-09-22
HUP0004085A3 (en) 2003-05-28
PT1036083E (pt) 2004-10-29
EE04681B1 (et) 2006-08-15
EP1036083A2 (en) 2000-09-20
DE69836697D1 (de) 2007-02-01
CA2306963A1 (en) 1999-04-29
ATE348836T1 (de) 2007-01-15
AR018014A1 (es) 2001-10-31
CN1280585A (zh) 2001-01-17
AU9362298A (en) 1999-05-10
ES2222610T3 (es) 2005-02-01
EP1036083B1 (en) 2004-05-26

Similar Documents

Publication Publication Date Title
KR100554549B1 (ko) 9a-아잘리드류로부터 유래한 신규한 3,6-헤미케탈
RU2045533C1 (ru) О-метильные производные азитромицина а, обладающие антибактериальной активностью, азитромицины в качестве промежуточных соединений для получения о-метильных производных азитромицина а и способ получения о-метильных производных азитромицина а
CA2327775C (en) 15-membered lactams ketolides with antibacterial activity
JP3056035B2 (ja) 9−デオキソ−9a−アザ−11−デオキシ−9a−ホモエリスロマイシンA 9a,11−環式カルバメート
EP1181298B1 (en) Novel 8a- and 9a-15-membered lactams
EP0262905A2 (en) Modifications of 3-0-demethyl-mycinose in macrocin and lactenocin
CZ20001319A3 (cs) Nové 3,6-hemiketaly ze třídy 9a-azalidů
HRP980497A2 (en) NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES
MXPA00003644A (en) NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES
HRP970551A2 (en) Novel o-methyl azythromycin derivatives
CZ20003704A3 (cs) 15-členné laktamové ketolidy s antibakteriální účinností
MXPA00009875A (es) Cetolidos de lactamas de 15 miembros con actividad antibacteriana

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee